The revenue stands at ₹2,831.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 8.72 per cent from ₹2,604.00 crore. This corresponds to a year-on-year *(YoY) growth of 9.52 per cent.
Operating Profit stands at ₹934.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 14.46 per cent from ₹816.00 crore. This corresponds to a year-on-year *(YoY) growth of 5.42 per cent.
PBDT stands at ₹1,083.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 20.60 per cent from ₹898.00 crore. This corresponds to a year-on-year *(YoY) growth of 11.53 per cent.
Profit Before Tax stands at ₹963.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 23.46 per cent from ₹780.00 crore. This corresponds to a year-on-year *(YoY) growth of 11.46 per cent.
Net Profit stands at ₹751.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.82 per cent from ₹583.00 crore. This represents a 13.44 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Divi's Lab. | 2.50% | 8.36% | 22.83% | 21.43% | 33.00% | 26.38% |
| Sun Pharma.Inds. | -0.87% | 0.82% | 6.63% | 9.07% | 23.56% | 22.13% |
| Torrent Pharma. | 5.14% | 2.05% | 10.31% | 20.41% | 28.19% | 39.35% |
| Cipla | 0.56% | 4.42% | 1.05% | 10.29% | 11.04% | -1.93% |
| Zydus Lifesci. | 1.10% | 1.62% | 1.55% | 24.88% | 28.13% | 18.66% |
Chairman & Managing Director : Murali K Divi
Executive Director : N V Ramana
Whole Time Director & Chief Executive Officer : Kiran S Divi
Chairman & Independent Director : Ramesh B V Nimmagadda
Whole Time Director- Commercial : Nilima Prasad Divi
Independent Director : S Ganapaty
Independent Director : Sunaina Singh
Independent Director : Kosaraju Veerayya Chowdary
Company Sec. & Compli. Officer : Satish Choudhury
Director (Manufacturing) : S. Devendra Rao
Independent Director : Rajendrakumar Premchand Shah